AI assistant
IMPEDIMED LIMITED — Capital/Financing Update 2014
Nov 19, 2014
65135_rns_2014-11-19_bdbc6c48-ef80-4f98-909d-c8c7864aeb1f.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [99 x 29] intentionally omitted <==
==> picture [99 x 29] intentionally omitted <==
==> picture [99 x 29] intentionally omitted <==
20 November 2014
FOR IMMEDIATE RELEASE
The Manager Company Announcements Office ASX Limited Level 4, Exchange Centre 20 Bridge Street SYDNEY NSW 2000
ImpediMed confirms number of shares to be issued under entitlement offer
As foreshadowed on 13 November 2014, ImpediMed Limited (ABN 65 089 705 144) (ASX: IPD) ( ImpediMed ) now confirms that it will issue a total of approximately 54.2 million new fully paid ordinary shares under its non-renounceable pro rata entitlement offer, raising a total of approximately A$32.5 mllion before costs and expenses.
The entitlement offer opens for acceptance by Eligible Shareholders (as defined in the Offer Booklet for the offer) at 9.00am (AEDT) on 24 November 2014. On that date, ImpediMed will send the Offer Booklet to Eligible Shareholders.
-ENDS-
For further details contact:
Steve Denaro
Company Secretary ImpediMed Limited T: +61 7 3860 3700
ImpediMed Limited ABN 65 089 705 144
Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com